Picture of Danaher logo

DHR — Danaher Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+0.85%
3m+1.58%
6m-9.59%
1yr+3.47%
Volume Change (%)
10d/3m-14.53%
Price vs... (%)
52w High-25.04%
50d MA-7.03%
200d MA-15.08%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)23.68
PEG Ratio (f)1.98
EPS Growth (f)13.57%
Dividend Yield (f)0.42%
Valuation (ttm)IndustryMarket
Price to Book Value4.22
Price to Tang. Bookn/a
Price to Free Cashflow25.41
Price to Sales6.01
EV to EBITDA20.8

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital9.95%
Return on Equity15.6%
Operating Margin24.91%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m15,518.817,04917,91122,28429,45330,707.8132,186.8911.77%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-11.26+9.79-6.12+36.56+98.95+19.81+5.76n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for DHR

Danaher share price hits a one-year high background image

Danaher share price hits a one-year high

Shares in Danaher (NYQ:DHR) are currently trading close to a 52 week high, with the share price up by around 2.80% to $274 over the past week. On a one-month basis, the Danaher price has risen by 13.2%. For investors holding the stock...

What does the future hold for the Danaher share price? background image

What does the future hold for the Danaher share price?

The Danaher (NYQ:DHR) share price has risen by 4.70% over the past month and it’s currently trading at 174.9. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue. A...

The Danaher share price – where next? background image

The Danaher share price – where next?

The Danaher (NYQ:DHR) share price has risen by 2.87% over the past month and it’s currently trading at 165.02. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....

Brokers upbeat on Danaher despite economic uncertainty background image

Brokers upbeat on Danaher despite economic uncertainty

The Danaher (NYQ:DHR) share price has risen by 11.0% over the past month and it’s currently trading at 160.27. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Danaher EPS forecast chart

Profile Summary

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Directors

Last Annual
December 31st, 2021
Last Interim
April 1st, 2022
Incorporated
October 3rd, 1986
Public Since
December 10th, 1969
No. of Shareholders
2,343
No. of Employees
78,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
727,076,766

DHR Share Price Performance

Latest News for DHR

Upcoming Events for DHR

Dividend For DHER34.SA - 0.3212 BRL

Dividend For DHR.N - 0.2500 USD

Dividend For DHR_pb.N - 12.5000 USD

Q2 2022 Danaher Corp Earnings Release

Q3 2022 Danaher Corp Earnings Release

Similar to DHR

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of AmerisourceBergen logo

AmerisourceBergen

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email